These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18070540)

  • 41. Neuroprotective effect of lignans extracted from Eucommia ulmoides Oliv. on glaucoma-related neurodegeneration.
    Li CP; Qiu GZ; Liu B; Chen JL; Fu HT
    Neurol Sci; 2016 May; 37(5):755-62. PubMed ID: 26829935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. What is the present pathogenetic concept of glaucomatous optic neuropathy?
    Flammer J; Mozaffarieh M
    Surv Ophthalmol; 2007 Nov; 52 Suppl 2():S162-73. PubMed ID: 17998042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discrimination of glaucomatous optic neuropathy by digital stereoscopic analysis.
    Morgan JE; Sheen NJ; North RV; Goyal R; Morgan S; Ansari E; Wild JM
    Ophthalmology; 2005 May; 112(5):855-62. PubMed ID: 15878066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Morphology of single ganglion cells in the glaucomatous primate retina.
    Weber AJ; Kaufman PL; Hubbard WC
    Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2304-20. PubMed ID: 9804139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retinal nerve fiber layer measurements using laser scanning polarimetry in different stages of glaucomatous optic nerve damage.
    Nguyen NX; Horn FK; Hayler J; Wakili N; Jünemann A; Mardin CY
    Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):608-14. PubMed ID: 12192453
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In glaucoma, should enthusiasm about neuroprotection be tempered by the experience obtained in other neurodegenerative disorders?
    Haefliger IO; Fleischhauer JC; Flammer J
    Eye (Lond); 2000 Jun; 14 ( Pt 3B)():464-72. PubMed ID: 11026975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Astrocytes in glaucomatous optic neuropathy.
    Hernandez MR; Miao H; Lukas T
    Prog Brain Res; 2008; 173():353-73. PubMed ID: 18929121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dendritic and synaptic protection: is it enough to save the retinal ganglion cell body and axon?
    Morquette JB; Di Polo A
    J Neuroophthalmol; 2008 Jun; 28(2):144-54. PubMed ID: 18562848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New findings in the evaluation of the optic disc in glaucoma diagnosis.
    Susanna R; Vessani RM
    Curr Opin Ophthalmol; 2007 Mar; 18(2):122-8. PubMed ID: 17301613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The case for autoimmunity in glaucoma.
    Wax MB
    Exp Eye Res; 2011 Aug; 93(2):187-90. PubMed ID: 20801114
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia.
    Tezel G; Yang X; Luo C; Peng Y; Sun SL; Sun D
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):705-14. PubMed ID: 17251469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reappraisal of the mechanisms of glaucomatous optic nerve damage.
    Quigley HA
    Eye (Lond); 1987; 1 ( Pt 2)():318-22. PubMed ID: 3115840
    [No Abstract]   [Full Text] [Related]  

  • 53. Neuroinflammation in Glaucoma and Optic Nerve Damage.
    Mac Nair CE; Nickells RW
    Prog Mol Biol Transl Sci; 2015; 134():343-63. PubMed ID: 26310164
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leptin as a neuroprotective agent in glaucoma.
    Gupta A
    Med Hypotheses; 2013 Nov; 81(5):797-802. PubMed ID: 24035688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The pathogenesis of glaucoma in the interplay with the immune system.
    Rieck J
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2393-409. PubMed ID: 23539162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relevance of the site of injury of glaucoma to neuroprotective strategies.
    Levin LA
    Surv Ophthalmol; 2001 May; 45 Suppl 3():S243-9; discussion S273-6. PubMed ID: 11377443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Central nervous system changes in glaucoma.
    Yücel Y
    J Glaucoma; 2013; 22 Suppl 5():S24-5. PubMed ID: 23733121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glaucomatous optic neuropathy management: the role of neuroprotective agents.
    L Shahsuvaryan M
    Med Hypothesis Discov Innov Ophthalmol; 2013; 2(2):41-6. PubMed ID: 24600641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resistance to the most common optic neuropathy is associated with systemic mitochondrial efficiency.
    Lascaratos G; Chau KY; Zhu H; Gkotsi D; King R; Gout I; Kamal D; Luthert PJ; Schapira AHV; Garway-Heath DF
    Neurobiol Dis; 2015 Oct; 82():78-85. PubMed ID: 26054436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of the Immune System for the Treatment of Glaucoma.
    Bell K; Und Hohenstein-Blaul NVT; Teister J; Grus F
    Curr Neuropharmacol; 2018; 16(7):942-958. PubMed ID: 28730968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.